Summary of the Key Points
This news highlights a new and emerging trend in China: high-end medical services for international patients. In simple terms, many foreign patients with the financial means are seeking treatment in China because the waiting times in their home countries' public healthcare systems are excessively long, and the costs of cutting-edge treatments are exorbitant. This particularly applies to treatments such as CAR-T for cancer and complex pediatric surgeries, where China has caught up with or even surpassed Europe and the United States in technology, while the prices are more than half lower. Both businesses that have been in the inbound tourism industry for years and domestic high-end private hospitals are quietly making moves in this area. The government has also provided clear support for this trend, and it does not compete with the public healthcare resources for domestic patients, representing a new market worth billions of yuan.
---
Detailed Analysis
1. Foreigners coming to China for treatment are not just looking for a bargain; they are truly seeking life-saving opportunities
Many might wonder why they would choose China over Europe or the United States for medical care, given that those countries have the best medical technology. There are three main practical reasons:
- Waiting times: The waiting times in free public healthcare systems in Europe and the United States are extremely long, with non-urgent surgeries often taking half a year or longer. For life-threatening conditions like cancer, patients with the means have to pay for private treatments, which can be very expensive. For example, a treatment like CAR-T in New Zealand costs $600,000, out of reach for most families.
- Cutting-edge technology: China has now reached the forefront in certain treatments. While the United States was the first to develop CAR-T, China has approved nine products, the highest number in the world, and has achieved "industrialized production." In China, these treatments can be completed in just a few weeks, whereas in other countries, it may take months.
- Cost differences: The cost of CAR-T in China is significantly lower—between $150,000 and $230,000, compared to $550,000 to $850,000 in the United States. Many foreign patients with comprehensive health insurance can cover these costs, allowing them to receive life-saving treatments several months earlier than they would in their home countries.
2. The entire industry is profiting significantly
The profits from this business are much higher than those from traditional inbound tourism. In the past, tour operators would earn a few thousand yuan per trip by showing tourists around attractions or serving hot pot. Now, as intermediaries in international medical services, they only need to provide translation, coordinate remote consultations with domestic hospitals, arrange transportation and accomodation, and provide follow-up care. They can charge a 10%-20% fee per transaction, which can amount to tens of thousands of yuan per case. Hospitals also benefit significantly; in Guangzhou alone, the revenue from international medical services last year reached 2.28 billion yuan, all in foreign currency. Even pharmaceutical companies benefit, as the increased demand reduces production costs.
3. No concern about foreign patients taking up domestic resources
There is no need to worry that foreign patients will compete with domestic patients for limited resources. Most foreign patients seek treatment at privately funded international hospitals like Shanghai Yaoying or Jiahui, which are independently funded and not part of the public healthcare system. Even if a few go to the international departments of public hospitals, they are in separate areas. Additionally, the government has set limits on the proportion of market-based services in public hospitals, ensuring they do not exceed 10% of total medical services.
4. High barriers to entry
Although the potential profits are attractive, the risks are also significant. Medical treatments involve uncertainties, and cross-border disputes can be costly. Misinterpretations of medical records can lead to complications. Moreover, there are no established rules for dividing responsibilities in such cases. This industry is still in its early stages, and making mistakes can result in substantial legal and financial losses.
5. A potential new source of foreign exchange for China
This business could become a new major source of revenue for China. While traditional exports have been low-value goods, exporting medical services can generate much higher profits. Currently, there are only about 70,000 foreign patients in Shanghai and 180,000 in Guangzhou each year. As success stories spread, millions of middle- and high-income patients from abroad who cannot afford treatment in their home countries will consider China as their first choice. This industry could grow into a billion-dollar industry, valued ten times more than traditional inbound tourism and potentially becoming another symbol of China's strength to the world, alongside high-speed railways and renewable energy.